Table 4.
Characteristics of subgroups depending on PC, PLR, and NPS.
| Variable | PC | p | PLR | p | NPS | p | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| <400 | >400 | <150 | ≥150 | 0 | 1 | 2 | ||||
| n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | n (%) | ||||
| Age | 0.0028 | 0.0016 | 0.0004 | |||||||
| <65 | 81 (77.1) | 24 (22.8) | 35 (33.3) | 70 (66.7) | 73 (69.5) | 23 (21.9) | 9 (8.6) | |||
| >65 | 129 (90.8) | 13 (9.1) | 76 (53.5) | 66 (46.5) | 127 (89.4) | 10 (7.1) | 5 (3.5) | |||
| Gender | 0.336 | 0.377 | 0.090 | |||||||
| Male | 92 (87.6) | 13 (12.4) | 44 (41.9) | 60 (58.1) | 88 (83.8) | 15 (14.3) | 2 (1.9) | |||
| Female | 118 (83.1) | 24 (16.9) | 68 (47.6) | 75 (52.4) | 112 (78.9) | 18 (12.7) | 12 (8.4) | |||
| BMI | 0.0278 | 0.0796 | 0.194 | |||||||
| ≤25 | 87 (79.1) | 23 (20.9) | 42 (38.2) | 68 (61.8) | 85 (77.3) | 15 (13.6) | 10 (9.1) | |||
| 25-30 | 71 (86.8) | 11 (13.4) | 36 (47.0) | 44 (53.0) | 66 (80.5) | 13 (15.9) | 3 (3.6) | |||
| ≥30 | 52 (94.6) | 3 (5.4) | 31 (56.4) | 24 (43.6) | 49 (89.1) | 5 (9.1) | 1 (1.8) | |||
| Tumor location | 0.172 | 0.577 | 0.172 | |||||||
| RCC | 66 (91.7) | 6 (8.3) | 34 (47.2) | 38 (52.8) | 63 (87.5) | 8 (11.1) | 1 (1.4) | |||
| LCC | 99 (81.8) | 22 (18.2) | 57 (47.1) | 64 (52.9) | 94 (77.7) | 16 (13.2) | 11 (9.1) | |||
| RC | 45 (83.3) | 9 (16.7) | 21 (38.9) | 33 (61.1) | 43 (79.6) | 9 (16.7) | 2 (3.7) | |||
| Grade | 0.324 | 0.596 | 0.760 | |||||||
| I | 15 (93.8) | 1 (6.2) | 6 (37.5) | 10 (62.5) | 14 (87.5) | 2 (12.5) | 0 (0) | |||
| II | 119 (86.2) | 19 (13.8) | 70 (50.7) | 68 (49.3) | 115 (83.3) | 16 (11.6) | 7 (5.1) | |||
| III | 43 (93.5) | 3 (6.5) | 22 (47.8) | 24 (52.2) | 41 (89.1) | 4 (8.7) | 1 (2.2) | |||
| Clinical stage | 0.0122 | 0.063 | 0.0046 | |||||||
| II | 47 (92.2) | 4 (7.8) | 29 (56.9) | 22 (43.1) | 47 (92.2) | 4 (7.8) | 0 | |||
| III | 60 (92.3) | 5 (7.7) | 32 (49.2) | 33 (50.8) | 58 (89.3) | 6 (9.2) | 1 (1.5) | |||
| IV | 103 (78.6) | 28 (21.4) | 51 (38.60) | 81 (61.4) | 95 (72.5) | 23 (17.6) | 13 (9.9) | |||